TARA Dividend: Protara Therapeutics Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

TARA Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	20	17	18	20	26	22
Research & Development	39	--	24	16	21	11
Operating Expenses	59	49	44	37	47	34
Other Non Operating Income (Expenses)	--	4	--	--	--	--
Pretax Income	-52	-45	-40	-65	-47	-33
Income Tax Expense	--	--	--	--	--	--
Net Income	-52	-45	-40	-65	-47	-33
Net Income Growth	27%	13%	-38%	38%	42%	136%
Shares Outstanding (Diluted)	42.27	21	11	11.26	11.23	7.23
Shares Change (YoY)	92%	91%	-2%	0%	55%	1,346%
EPS (Diluted)	-1.25	-2.14	-3.63	-5.86	-4.21	-4.7
EPS Growth	-34%	-41%	-38%	39%	-10%	-84%
Free Cash Flow	-48	-35	-37	-26	-35	-24
Free Cash Flow Per Share	-1.13	-1.66	-3.36	-2.3	-3.11	-3.31
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-59	-49	-44	-37	-47	-34
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-59	-49	-44	-37	-47	-34
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--